- Q1 2024 Viridian Therapeutics Inc Earnings Call TranscriptMay 08, 2024$14.9 (-1.59%)Earnings
- Viridian Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 11, 2024
- Viridian Therapeutics Inc Subcutaneous IGF-1R Program Selection TranscriptDec 18, 2023
- Viridian Therapeutics Inc VRDN-001 Chronic TED Data Conference Call TranscriptJul 10, 2023
- Q1 2023 Viridian Therapeutics Inc Earnings Call TranscriptMay 09, 2023$25.68 (+0.75%)Earnings
- Q4 2022 Viridian Therapeutics Inc Earnings Call TranscriptMar 08, 2023$29.47 (-10.48%)Earnings
- Viridian Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Q3 2022 Viridian Therapeutics Inc Earnings Call TranscriptNov 14, 2022$20.32 (-0.93%)Earnings
- Q2 2022 Viridian Therapeutics Inc Earnings Call TranscriptAug 15, 2022$22 (+49.36%)Earnings
- Q1 2022 Viridian Therapeutics Inc Earnings Call TranscriptMay 12, 2022$10.56 (+5.49%)Earnings
- Q4 2021 Viridian Therapeutics Inc Earnings Call TranscriptMar 10, 2022$19.04 (-3.05%)Earnings
- Viridian Therapeutics Inc at Ladenburg Thalmann Virtual Healthcare Conference TranscriptJul 14, 2021
- Viridian Therapeutics Inc Annual Shareholders Meeting TranscriptJun 03, 2021
- Q4 2020 Viridian Therapeutics Inc Earnings Call TranscriptMar 25, 2021$17.27 (-1.26%)Earnings
- Viridian Therapeutics Inc at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- miRagen Therapeutics Inc Extraordinary Shareholders Meeting TranscriptDec 31, 2020
- Miragen Therapeutics, Inc., Viridian Therapeutics, Inc. - M&A Call TranscriptOct 28, 2020
- Q2 2020 miRagen Therapeutics Inc Earnings Call TranscriptAug 05, 2020$17.55 (+2.63%)Earnings
- Miragen Therapeutics - Special Call TranscriptJun 23, 2020
- miRagen Therapeutics Inc Annual Shareholders Meeting TranscriptMay 21, 2020
- Q1 2020 miRagen Therapeutics Inc Earnings Call TranscriptMay 07, 2020$8.25 (-3.51%)Earnings
- Q4 2019 miRagen Therapeutics Inc Earnings Call TranscriptMar 11, 2020$9.18 (-8.44%)Earnings
- Miragen Therapeutics, Inc. - Special Call TranscriptDec 11, 2019
- Q3 2019 miRagen Therapeutics Inc Earnings Call TranscriptNov 07, 2019$10.68 (-3.78%)Earnings
- Q2 2019 miRagen Therapeutics Inc Earnings Call TranscriptAug 07, 2019$23.55 (+18.05%)Earnings
- miRagen Therapeutics Inc Annual Shareholders Meeting TranscriptJun 19, 2019
- Q1 2019 miRagen Therapeutics Inc Earnings Call TranscriptMay 08, 2019$42.15 (-0.35%)Earnings
- Q4 2018 miRagen Therapeutics Inc Earnings Call TranscriptMar 13, 2019$39.75 (+3.52%)Earnings
Viridian Therapeutics Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone. My name is Lalita Sundarrajan. And it's my pleasure to introduce Viridian Therapeutics speakers for today, President and CEO, Steve Mahoney, joined onstage by our Chief Business Officer, Shan Wu. With that, Steve, I'll turn it over to you.
Thank you very much, Lalita. Good morning, everyone, and thank you for joining us. I am pleased to be here today to tell you about Viridian. We are very excited about 2024, the year ahead.
Viridian is building what we believe to be a world-class portfolio in two key areas: thyroid eye disease with a potential best-in-class therapy for thyroid eye disease and a portfolio of FcRns that are differentiated from and improved upon current products and those that are also in development.
Before we get started, I'd like to mention that we will be making forward-looking statements today. They are subject to risks and uncertainties, and we refer you
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)